Aclaris Therapeutics, Inc. (ACRS)
3.75
-0.08
(-2.09%)
USD |
NASDAQ |
Oct 23, 16:00
3.755
0.00 (0.00%)
After-Hours: 20:00
Aclaris Therapeutics Market Cap : 524.34M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 524.34M |
| October 22, 2026 | 535.53M |
| October 21, 2026 | 532.73M |
| October 20, 2026 | 527.14M |
| October 19, 2026 | 486.59M |
| October 16, 2026 | 458.62M |
| October 15, 2026 | 487.99M |
| October 14, 2026 | 472.61M |
| October 13, 2026 | 485.19M |
| October 12, 2026 | 503.37M |
| October 09, 2026 | 535.53M |
| October 08, 2026 | 529.93M |
| October 07, 2026 | 475.40M |
| October 06, 2026 | 517.35M |
| October 05, 2026 | 597.05M |
| October 02, 2026 | 613.83M |
| October 01, 2026 | 616.63M |
| September 30, 2026 | 735.48M |
| September 29, 2026 | 738.27M |
| September 28, 2026 | 759.25M |
| September 25, 2026 | 720.10M |
| September 24, 2026 | 752.25M |
| September 23, 2026 | 735.48M |
| September 22, 2026 | 799.80M |
| September 21, 2026 | 778.82M |
| Date | Value |
|---|---|
| September 18, 2026 | 769.03M |
| September 17, 2026 | 755.05M |
| September 16, 2026 | 743.87M |
| September 15, 2026 | 772.53M |
| September 14, 2026 | 788.61M |
| September 11, 2026 | 743.87M |
| September 10, 2026 | 769.73M |
| September 09, 2026 | 777.42M |
| September 08, 2026 | 847.34M |
| September 04, 2026 | 862.72M |
| September 03, 2026 | 831.95M |
| September 02, 2026 | 864.11M |
| September 01, 2026 | 841.74M |
| August 31, 2026 | 845.94M |
| August 28, 2026 | 840.34M |
| August 27, 2026 | 861.32M |
| August 26, 2026 | 865.51M |
| August 25, 2026 | 913.75M |
| August 24, 2026 | 882.29M |
| August 21, 2026 | 896.27M |
| August 20, 2026 | 885.09M |
| August 19, 2026 | 900.47M |
| August 18, 2026 | 881.59M |
| August 17, 2026 | 827.76M |
| August 14, 2026 | 808.18M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Corcept Therapeutics, Inc. | 9.266B |
| Alumis, Inc. | 871.27M |
| ANI Pharmaceuticals, Inc. | 1.668B |
| Veru, Inc. | 38.19M |
| Johnson & Johnson | 635.02B |
Market Cap Related Metrics
| PS Ratio | 58.95 |
| Price to Book Value | 4.209 |
| Price | 3.75 |
| Earnings Yield | -15.61% |